Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Schramm

Showing results (181-190 of 228) with videos related to

Pageof 23
Sort By:
International Journal of Cancer|November 2, 2007
Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomicsJo Vandesompele, Evi Michels, Katleen De Preter, et al.
Oncotarget|November 27, 2016
Targeting tachykinin receptors in neuroblastomaAnton G Henssen, Andrea Odersky, Annabell Szymansky, et al.
Translational Oncology|November 20, 2021
Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancerMartin Metzenmacher, Balazs Hegedüs, Jan Forster, et al.
Cancer Research|February 19, 2009
Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapyJohannes H Schulte, Soyoung Lim, Alexander Schramm, et al.
Plos One|October 9, 2014
Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsamplingSangkyun Lee, Jörg Rahnenführer, Michel Lang, et al.
International Journal of Cancer|January 6, 2011
Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinomaHagen S Bachmann, Lukas C Heukamp, Klaus J Schmitz, et al.
International Journal of Cancer|October 19, 2007
MYCN regulates oncogenic MicroRNAs in neuroblastomaJohannes H Schulte, Sebastian Horn, Tobias Otto, et al.
International Journal of Cancer|May 18, 2010
Accurate prediction of neuroblastoma outcome based on miRNA expression profilesJohannes H Schulte, Benjamin Schowe, Pieter Mestdagh, et al.
Cell Death Discovery|April 5, 2022
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastomaKai Voeltzke, Katerina Scharov, Cornelius Maximilian Funk, et al.
Oncoimmunology|September 18, 2018
Evolution of melanoma cross-resistance to CD8Natalia Pieper, Anne Zaremba, Sonia Leonardelli, et al.
Pageof 23

Showing results (181-190 of 228) with videos related to

Sort By:
Pageof 23
International Journal of Cancer|November 2, 2007
Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomicsJo Vandesompele, Evi Michels, Katleen De Preter, et al.
Oncotarget|November 27, 2016
Targeting tachykinin receptors in neuroblastomaAnton G Henssen, Andrea Odersky, Annabell Szymansky, et al.
Translational Oncology|November 20, 2021
Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancerMartin Metzenmacher, Balazs Hegedüs, Jan Forster, et al.
Cancer Research|February 19, 2009
Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapyJohannes H Schulte, Soyoung Lim, Alexander Schramm, et al.
Plos One|October 9, 2014
Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsamplingSangkyun Lee, Jörg Rahnenführer, Michel Lang, et al.
International Journal of Cancer|January 6, 2011
Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinomaHagen S Bachmann, Lukas C Heukamp, Klaus J Schmitz, et al.
International Journal of Cancer|October 19, 2007
MYCN regulates oncogenic MicroRNAs in neuroblastomaJohannes H Schulte, Sebastian Horn, Tobias Otto, et al.
International Journal of Cancer|May 18, 2010
Accurate prediction of neuroblastoma outcome based on miRNA expression profilesJohannes H Schulte, Benjamin Schowe, Pieter Mestdagh, et al.
Cell Death Discovery|April 5, 2022
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastomaKai Voeltzke, Katerina Scharov, Cornelius Maximilian Funk, et al.
Oncoimmunology|September 18, 2018
Evolution of melanoma cross-resistance to CD8Natalia Pieper, Anne Zaremba, Sonia Leonardelli, et al.
Pageof 23